LicenseTheData.comA field guide to business-data licensing
Home/Comparisons

Public evidence · 13 October 2026

Appen vs Datarade

Direct licensing meets marketplace. Neither advertised amounts nor a public seller route establish what your business will receive.

Jump to the terms ledger ↓

Research comparison; limited public terms. Pair-level evidence and scenario review is pending. Published fields alone do not meet our indexing threshold. This page is noindex and absent from the sitemap, not a negative verdict.

The terms ledger.

Headquarters or contact location is not seller eligibility. Response, acceptance and payout stages are not interchangeable.

Published descriptions and unresolved contract terms
CriterionAppenDatarade
Operating recordsPublished
SOPs, wikis, approval chains, support/ITSM/CRM, ERP, messaging, BI, contracts, HR/payroll
Source ↗
Published
Broad dataset categories and AI-ready data products
Source ↗
Company eligibilityPublished
Operating or winding-down companies; no size minimum published.
Source ↗
Published
Application reviewed for company, datasets, buyer fit and quality
Source ↗
Seller geographyUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Published
Global reach claimed; provider legal eligibility not blanket guaranteed
Source ↗
Published compensationProvider claim
Individually quoted by rarity, structure and history.
Source ↗
Provider claim
Seller-priced product sales / leads; third-party buyers purchase
Source ↗
Fees & net proceedsPublished
No costs, setup fees or deductions.
Source ↗
Published
Commission-only $0/year +30%; Bronze $6,000/year +20%; Gold custom. Advertised dollar pricing; currency not independently established in this research.
Source ↗
Timeline & payment triggerProvider claim
Payment on acceptance; two-business-day response is not a payout deadline.
Source ↗
Provider claim
3-minute application; 1–2 business-day review claimed; no first-sale/payout SLA
Source ↗
Preparation & seller effortPublished
Register → NDA → written scope → extraction → representative sample sign-off → license.
Source ↗
Published
Provider Studio application
Source ↗
Ownership & permitted usePublished
Retains ownership.
Source ↗
Unknown
Not published / not established
Not established in inspected sources; confirm in contract.
Privacy & approvalProvider claim
Read-only encrypted isolated pipelines; anonymization or synthetic rewrites; buyers/third parties do not see raw data; retention/deletion agreed before extraction.
Source ↗
Unknown
Not published / not established
Not established in inspected sources; confirm in contract.
ExclusivityUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Unknown
Not published / not established
Not established in inspected sources; confirm in contract.
Retention & deletionPublished
Retention/deletion follow agreed terms; no public exact duration.
Source ↗
Unknown
Not published / not established
Not established in inspected sources; confirm in contract.
HQ / published contactPublished
Corporate HQ Sydney, Australia; US HQ Kirkland, Washington, according to program page.
Source ↗
Published
Germany; Berlin; seller eligibility is separate.
Source ↗

Operating records

AppenPublished
SOPs, wikis, approval chains, support/ITSM/CRM, ERP, messaging, BI, contracts, HR/payroll
Source ↗
DataradePublished
Broad dataset categories and AI-ready data products
Source ↗

Company eligibility

AppenPublished
Operating or winding-down companies; no size minimum published.
Source ↗
DataradePublished
Application reviewed for company, datasets, buyer fit and quality
Source ↗

Seller geography

AppenUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
DataradePublished
Global reach claimed; provider legal eligibility not blanket guaranteed
Source ↗

Published compensation

AppenProvider claim
Individually quoted by rarity, structure and history.
Source ↗
DataradeProvider claim
Seller-priced product sales / leads; third-party buyers purchase
Source ↗

Fees & net proceeds

AppenPublished
No costs, setup fees or deductions.
Source ↗
DataradePublished
Commission-only $0/year +30%; Bronze $6,000/year +20%; Gold custom. Advertised dollar pricing; currency not independently established in this research.
Source ↗

Timeline & payment trigger

AppenProvider claim
Payment on acceptance; two-business-day response is not a payout deadline.
Source ↗
DataradeProvider claim
3-minute application; 1–2 business-day review claimed; no first-sale/payout SLA
Source ↗

Preparation & seller effort

AppenPublished
Register → NDA → written scope → extraction → representative sample sign-off → license.
Source ↗
DataradePublished
Provider Studio application
Source ↗

Ownership & permitted use

AppenPublished
Retains ownership.
Source ↗
DataradeUnknown
Not published / not established
Not established in inspected sources; confirm in contract.

Privacy & approval

AppenProvider claim
Read-only encrypted isolated pipelines; anonymization or synthetic rewrites; buyers/third parties do not see raw data; retention/deletion agreed before extraction.
Source ↗
DataradeUnknown
Not published / not established
Not established in inspected sources; confirm in contract.

Exclusivity

AppenUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
DataradeUnknown
Not published / not established
Not established in inspected sources; confirm in contract.

Retention & deletion

AppenPublished
Retention/deletion follow agreed terms; no public exact duration.
Source ↗
DataradeUnknown
Not published / not established
Not established in inspected sources; confirm in contract.

HQ / published contact

AppenPublished
Corporate HQ Sydney, Australia; US HQ Kirkland, Washington, according to program page.
Source ↗
DataradePublished
Germany; Berlin; seller eligibility is separate.
Source ↗

Which difference matters to your company?

Buyer relationship

If you already have a marketable data product, compare distribution rather than headline payouts: Appen is direct licensing, while Datarade is marketplace. Listing or matching creates no purchase commitment; ask who actually signs and pays.

Appen: source 1 ↗ Datarade: source 1 ↗ source 2 ↗ Public descriptions, not tested seller outcomes.

Data fit

For your existing records, start with category fit: Appen lists SOPs, wikis, approval chains, support/ITSM/CRM, ERP, messaging, BI, contracts, HR/payroll; Datarade lists Broad dataset categories and AI-ready data products. Ask each which subset has active demand before preparing exports.

Appen: source 1 ↗ Datarade: source 1 ↗ source 2 ↗ Public descriptions, not tested seller outcomes.

Payment trigger

Appen: Payment on acceptance; two-business-day response is not a payout deadline. Datarade: 3-minute application; 1–2 business-day review claimed; no first-sale/payout SLA These clocks measure different stages, not equivalent payout deadlines; ask for a written acceptance-to-payment interval.

Appen: source 1 ↗ Datarade: source 1 ↗ source 2 ↗ Public descriptions, not tested seller outcomes.

Shared diligence, not shared guarantees.

Both routes need lawful rights to the material. Removing names does not remove confidentiality obligations or re-identification risk. Require sample approval, buyer-use restrictions, precise payment triggers and downstream retention/deletion terms.

Seller-outcome evidence

Appen: No independently audited operating-business payout established in this research. Provider cases and partnership confirmations do not establish a typical seller outcome.

Datarade: No independently verified operating-business seller payout found. Marketplace listing or matching is not a purchase commitment.

Put two routes side by side.

Choose two different providers. No income ranking.

Sources & unknowns.

Source claims were inspected on 13 October 2026. No intake was submitted or transaction tested. Unknowns are not zero fees, universal eligibility or unrestricted rights.

Read the evidence and indexing methodology →